FDA
approval
· 2023-05-23
FDA Approved: NOVAREL — Supplemental Application (Ferring Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for NOVAREL (chorionic gonadotropin) from Ferring Pharmaceuticals, indicating a regulatory update to the product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NOVAREL (GONADOTROPHIN, CHORIONIC)